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Background: Asthma is the most common chronic childhood disease. Imbalance of cytokines released from T
helper cells and environmental factors, such as exposure to poly-aromatic hydrocarbon (PAH), play pivotal roles in
the pathogenesis of asthma. The aim of this study was to compare the mRNA expression patterns of Interleukin
(IL)-4, interferon (IFN)-γ and Acyl Co A long chain 3 (ACSL3) in peripheral blood leukocytes of children with and
without asthma. To correlate the obtained mRNA data with serum IL-4, IFN-γ and PAH levels. Further, to determine
the effect of in vivo exposure to PAH on mRNA expression of IL-4, IFN-γ and ACSL3 genes in a rat model.
Methods: A total of 170 children below 16 years (85 pediatric asthma patients and 85 matched healthy controls) were
randomly selected from the Riyadh Cohort, Saudi Arabia. Gene expression analysis was performed using qRTPCR.
Serum IL-4, IFN-γ and PAH were measured using LINCOplex (human multiplex immunoassay kit) and HPLC respectively.
Results: IL-4 mRNA expression was significantly increased (P < 0.05) in children with asthma compared to healthy
control group whereas no differences were observed for either IFN-γ or ACSL3 mRNA. Similarly, serum IL- 4 and PAHs
concentration was significantly higher as well in children with asthma in whom IFN-γ was also significantly lower.
Results obtained in rats showed that exposure to the benzopyrene prototype PAH resulted in a 2.6 fold (P < 0.001)
increased IL-4 mRNA expression in blood.
Conclusion: Peripheral blood IL-4 mRNA levels, serum concentration of this cytokine are elevated in children with
asthma. Also, elevated levels of PAH were observed in children with asthma. Additionally, PAH administration in rodents
resulted in an increased IL-4 mRNA which is supposed to partly mediate the inflammatory response noted in asthma.
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Asthma is the most common chronic childhood disease;
this disease is characterized by variable airflow obstruc-
tion, inflammation of the airways and bronchial hyper-
responsiveness, and its prevalence is increasing in Saudi
Arabia [1,2]. The overall prevalence of asthma in Saudi
children has been described to ranges from 8% to 25%
based on studies carried out over the past three decades* Correspondence: aldaghri2011@gmail.com
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reproduction in any medium, provided the or[3]. The pathogenesis of asthma has been related to an
imbalance of cytokines released from T helper (Th) cells,
[4] with an increase in Th2 type cytokines (Interleukin
(IL) IL-4, IL-5, and IL-13) and a decrease in Th1 cyto-
kines (IFN-γ and IL-2). IL-4 is a key cytokine in the de-
velopment of allergic inflammation. The elevated serum
levels of IL-4, an essential cofactor for immunoglobulin
E (IgE) production, and IL-5, responsible for the final
differentiation, activation and recruitment of eosinophils,
have been found in patients with asthma [5]. IFN-γ
down regulates IL-4 production and its levels are
thought to be unaltered in asthmatic patients [6]. Fluid
recovered by bronchoalveolar lavage (BAL) from asth-
matic airways is enriched with IL-4, IL-5, IL-13 andral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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CSF) but not IFN-γ, indicating the presence of Th2 subclass
CD4+ lymphocytes [7]. ACSL3 belongs to the acyl-CoA
synthetase long chain (ACSL) family of genes which en-
codes key enzymes in fatty acid metabolism [8-10]. ACSL3
has been shown to be associated with asthma susceptibil-
ity in specific populations [11,12].
The pathogenesis of asthma is suggested to center
around immunological and environmental factors. In
particular, factors, such as living in high traffic urban
areas and exposure to diesel exhaust particles, repeated
exposure to polycyclic aromatic hydrocarbons (PAHs)
derived largely from incomplete combustion of organic
material, such as fossil fuels; coal, wood and tobacco
could be associated with early development of asthma-
related symptoms [2,13].
Several studies have been reported the expression cyto-
kine mRNA in BAL cells, bronchial mucosa and induced
sputum of asthmatic patients [14]. Studies of peripheral
blood T cells in adult asthma suggested that the proper-
ties of these cells reflected those of cells in the BAL and
bronchial mucosa [15]. The use of blood for gene expres-
sion studies offers an advantage over other tissues be-
cause of easy accessibility and, therefore, of great interest
for clinical studies and human experimental research
[16]. We focused on the expression of IL-4, IFN-γ and
ACSL3 mRNA in peripheral blood mononuclear cells
(PBMC) of Saudi children with and without asthma and
sought possible associations between cytokines and PAH
levels. Further, to analyze the possible effect of in vivo ex-
posure to PAH (Benzopyrene) on IL-4, IFN-γ and ACSL3
mRNA expression, we extended our study and tested the
effect of chronic exposure to PAH in Wistar albino rats.
Methods
Subjects and study protocol
A total of 170 (85 asthmatic, 85 non-asthmatic) Saudi
children and adolescents (16 years old and below) partic-
ipated in this cross-sectional study. The subjects were
selected randomly from the national biomarker screen-
ing, biomarkers research program, King Saud University
(KSU), Riyadh, Kingdom of Saudi Arabia (KSA). Ethical
approval was granted by the Ethics Committee of King
Saud University, Riyadh, Saudi Arabia. Children with
asthma were selected based on established pediatric
diagnosis and medications taken. The parent or guardian
of each child were asked to sign a consent form and to
answer a questionnaire including demographic informa-
tion, dietary questions, area of residence (e.g. near the
factory, high-traffic area, etc.), presence of a smoker at
home and other pertinent questions related to asthma.
Asthma wheeze was monitored using international study
of asthma and allergies in childhood (ISAAC) question-
naire for wheeze assessment.Clinical and biochemical measurements
Clinical and anthropometric parameters, including blood
pressure, weight, height and hip and waist circumfer-
ences were measured following standard procedures.
Body mass index (BMI) was calculated as weight/height2
(Kg/m2). Fasting blood samples were collected and the
serum glucose, triglyceride, total and HDL-cholesterol
levels were measured by chemistry auto-analyzer (Konelab,
Espoo, Finland) and concentrations of LDL-cholesterol
were calculated using Friedwald's formula. IL-4 and IFN-γ
concentrations were measured using LINCOplex, human
multiplex immunoassay kit based on Luminex 100 system
platform (Luminex Corporation, Austin, TX, USA) with
an intra-assay variability of <10% and inter-assay variation
of <15%. All fasting samples fell within the detection
range.
Quantitation of PAH in serum samples
PAH was measured in serum samples using HPLC ac-
cording to a previously described method [2]. A stock
solution of 12 PAHs mixed standard solutions was pre-
pared by dissolving 1 mg from each PAH in 100 ml
acetonitrile. The series of PAHs mix standard (0.0, 0.5,
2.5, 5, 10, 50 and 100 ng ml-1) were prepared in aceto-
nitrile for linearity. Calibration curves were generated by
plotting peak area versus concentration. Each subject’s
sample was analyzed for a suite of 12 PAHs as previously
described [17]. Analytical determination was conducted
by using liquid-liquid extraction followed by high
performance liquid chromatography with fluorescence
detector (HPLC-FLD). Standard calibration curve was
presented excellent linearity, with good separation and
repeatability. The limit of detection (LOD) was defined
as the higher value of either the method blank LOD
(three times standard deviation of method blank after
subtracting the average blank), or the instrument LOD
(signal >3 times the signal to noise ratio). The limit of
quantification (LOQ) (signal >10 times the signal to
noise ratio). The limits of detection were ranged from
1.2 to 4.0 ng ml-1 (0.001 ppm). The lowest possible
standard on the calibration curve was accepted as the
LOQ. The calibration curve and recovery validation
study were all repeated three times (n = 3). Recovery and
precision were estimated by using spiked blank matrix,
samples were analysed in duplicate at five levels spread
equally over the analytical range. The recoveries were
calculated from the analytical signal as the ratio between
found and expected expressed in %. The rate of recovery
for all 12 PAHs were ranged from 86 to 106%.
Animals and treatment schedule
Adult male Wistar albino rats (8 weeks old, weighing
200 ± 10 g), were obtained from the experimental animal
Care Center, College of Pharmacy, KSU, Riyadh, KSA.
Table 1 Summary of primer sequences used PCR
amplifications
Primers for
humans
Sequences Product size
GAPDH-F GAAGGTGAAGGTCGGAGTC 226
GAPDH-R GAAGATGGTGATGGGATTTC
IL-4-F CACA ACTGAGAAGGAAACCTTC TG 253
IL-4-R CTCTCTCATGATCGTCTT TAGCCT TTC
IFN-γ-F GCAGGTCATTCAGATGTAGCGG 181
IFN-γ-F TGTCTTCCT TGATGGTCTCCACAC
ACSL3-F GAGAGTTTGAACCCGATGGA 186
ACSL3-R TTGGCACAACAAATCCAATG
Primers for rats Sequences Product size
β-actin-F TTACTGCCCTGGCTCCTA 144
β-actin-R ACTCATCGTACTCCTGCTTG
IL-4-F CCACGGAGAACGAGCTCATC 101
IL-4-R GAGAACCCCAGACTTGTTCTTCA
IFN-γ-F CCCTCTCTGGCTGTTACTGC 149
IFN-γ-R TTTCGTGTTACCGTCCTTTTG
ACSL3-F GATTGGCTACTCTTCACC 223
ACSL3-R GAAATCTGCTCCATCTTAT
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conditions (25 ± 2°C and a 12 h light/dark cycle). Animals
had free access to food and water ad libitum. The protocol
of this study was been approved by Research ethics com-
mittee of College of science, KSU, Riyadh, KSA.
A total of 20 rats were divided into two groups of 10
animals each. Group 1 animals (control group) received
an intraperitoneal (i.p.) injection of Benzopyrene (10 mg/
kg body weight) for 3 weeks. Animals from group II were
injected with normal saline for the same period and were
used as control. After 3 weeks of treatment, blood was
collected from retro-orbital plexus and animals from both
the groups were sacrificed by cervical dislocation. Liver
and lung tissues were excised and stored in an all protect
tissue reagent (QIAGEN, Hilden, Germany) for further
analysis.
RNA extraction and cDNA synthesis
RNA from peripheral blood was extracted using a
leukocyte RNA purification kit (Norgen Biotek, Thorold,
Canada) according to the manufacturer’s instructions,
while on column DNAse treatment was performed using
RNase-Free DNase I Kit (NorgenBiotek). RNA concen-
trations were quantified by measuring the optical density
at 260-nm wavelengths using the Nano-drop ND-1000
spectrophotometer. Purity was determined as the 260/
280 nm ratio with expected values between 1.8 and 2.0,
indicating absence of protein contamination. The reverse-
transcription step was conducted on 500 ng of RNA using
the quantitect reverse transcription kit (QIAGEN, Hilden,
Germany).
Quantitaive real time PCR (qRTPCR)
All the experiments were performed in 96 well plates
with CFX 96 Real-Time PCR detection system (Bio-Rad,
CA, USA). mRNA expression of ACSL3, IL4 and IFN-γ
genes was normalized to the house keeping gene, beta
actin and GAPDH (Primer sequences for each were pre-
sented in Table 1). Each sample was analyzed in tripli-
cate alongside with negative control. RT-PCR was used
to amplify the target genes using the cDNA according to
the manufacturer’s instructions. Briefly, 1 μl of cDNA
was used in a final PCR volume of 20 μl, containing
10 μl of ready-mix (KAPA Biosystems) containing SYBR
green, Taq polymerase and buffers, 7 μl of water and
2 μl of left and right primers for housekeeping and tar-
get genes. PCR cycles were as follows: three minutes at
95°C followed by 40 cycles of fifteen seconds at 95°C,
thirty seconds at 60°C and thirty seconds at 72°C and
the data were obtained as cycle threshold (Ct) values.
Statistical analyses
Statistical analyses were performed using SPSS version 16.0
(Chicago, IL, USA). Data was represented as a means ±standard deviation. All anthropometrics and clinical pa-
rameters were compared between groups by one way
Analysis of Variance (ANOVA) followed by Bonferroni
post hoc test. The P values less than or equal to 0.05 were
accepted to indicate statistically significant difference. The
2-ΔΔCt method was used to quantify gene expression [18].
Results
The anthropometric, clinical and biochemical features of
the subjects are presented in Table 2. Children with
asthma had significantly lower HDL cholesterol levels
than the healthy control group.
IL-4, IFN-γ and ACSL3 mRNA in PBMC
mRNA levels were analyzed in freshly prepared RNA
from blood. Data are shown as the fold difference in
mRNA levels measured in samples of children with
asthma compared to those from healthy control subjects
(considered as referent with fold expression = 1).
No differences were observed between the asthmatic
and healthy control group with respect to IFN-γ and
ACSL3 mRNA expression (Figure 1A). In contrast, IL-4
mRNA levels were significantly higher (2.1 fold) (P < 0.05)
in the asthma compared to the control group (Figure 1B).
Serum cytokines and PAH levels
Serum levels of IL-4 and IFN-γ in the two groups ana-
lyzed are summarized in Figure 2. Serum IL- 4 levels
Table 2 Demographics and biochemical characteristics of
studied subjects
Non-asthmatic Asthmatic p
N 85 85
Age 13.2 ± 2.2 13.7 ± 2.3 0.16
BMI (kg/m2) 21.2 ± 5.5 21.3 ± 5.9 0.91
Waist (cm) 66.7 ± 15.1 68.2 ± 16.2 0.54
Hips (cm) 82.8 ± 20.0 83.4 ± 19.6 0.84
SAD (cm) 17.6 ± 7.5 17.7 ± 8.0 0.93
Systolic BP (mmHg) 104.3 ± 9.8 105.8 ± 10.1 0.34
Diastolic BP (mmHg) 68.1 ± 7.8 69.1 ± 8.4 0.43
Cholesterol (mmol/l) 4.3 ± 0.88 4.2 ± 0.79 0.45
Triglyceride (mmol/l) 1.1 ± 0.66 1.0 ± 0.41 0.25
LDL cholesterol (mmol/l) 2.8 ± 0.80 2.7 ± 0.67 0.40
HDL cholesterol (mmol/l) 1.05 ± 0.34 0.88 ± 0.31 0.001
Fasting blood
glucose (mmol/l)
5.2 ± 1.6 5.3 ± 1.7 0.70
Σ POP (ng/ml)* 21.8 (5.9, 309.3) 99.6 (64.4, 237.6) <0.001
Note: Data represented by Mean ± standard deviation.*-Data represented by
Median (Inter-quartile range). Independent sample t-test was performed for
comparing asthmatic and healthy control. Σ POP represents summation of
PAH measured (i.e. Naphthalene, Anthracene, Fluorene, Phenanthrene, 4H
cyclobenta[def]phenanthrene, Pyrene, Flouranthene, 1,2-benzanthracene,
Chrysene ,Benzo(e)pyrene, Benzoacephenanthrylene and Benzo(a)pyrene).
P-value significant at p < 0.05.
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healthy controls [(26.2 ± 2.6 versus 18.2 ± 1.3 ng/ml) (p =
0.01)]. In contrast, serum levels of IFN-γ were significantly
lower in children with asthma than in healthy controls
[(1.8 ± 0.69 versus 2.4 ± 0.74 ng/ml)] (p = 0.04).Figure 1 The expression of ACSL3, IFN-γ and IL-4 mRNA in (A) whole
blood from asthmatic patients. A: The expression of ACSL3, IFN-γ and IL
difference in ACSL3, IFN-γ and IL-4 transcript levels from treated group com
by quantitative reverse transcription–polymerase chain reaction. Fold chang
of the means. B: The expression of ACSL3, IFN-γ and IL-4 mRNA in periphe
IL-4 transcript levels from asthmatic patients compared to transcript level fr
reverse transcription–polymerase chain reaction. Fold change in mRNA leveMeasurement of PAHs, including Naphthalene, Anthra-
cene, Fluorene, Phenanthrene, 4H cyclobenta[def]phenan-
threne, Pyrene, Fluoranthene, 1,2-benzanthracene,chrysene,
benzo(e)pyrene, Benzoacephenanthrylene and Benzo(a)
pyrene was performed next. Σ POP was calculated by
summing up all the above parameters. Mean serum level
of PAH was significantly increased in asthma group com-
pared to control individuals [98.8 (63.4, 237.6) versus 22.9
(6.0, 309.3) ng/ml] (p < 0.001) (Table 2).
Relative expression of IL-4 and IFN- γ related with PAHs
Multivariate analysis using linear regression model
showed that IL4 and IFN-γ gene expression levels were
significantly correlated with serum PAH levels (Figure 3).
Correlation remained significant even after controlling
for age or the BMI (Table 3).
Chronic exposure to PAH in the animal model
Compared to the untreated group the treated group of
rats had significantly increased IL-4 mRNA expression
by 2.6 fold (P < 0.001) (Figure 1A). However, no differ-
ences were observed between the treated and untreated
group of rats with respect to IFN-γ and ACSL3 mRNA
expression.
Discussion
In this study, we investigated the expression of IL-4,
IFN-γ and ACSL3 mRNA in PBMCs of the children with
and without asthma and speculated that cytokine expres-
sion in PBMCs may provide useful information regarding
the allergic disease. The results of the present study
indicate that leukocyte IL-4 mRNA is over expressed inblood from rats treated with benzopyrene and (B) peripheral
-4 mRNA in whole blood from rats treated with benzopyrene. Fold
pared to transcript level from untreated as referent = 1, as determined
e in mRNA level shown under each bar. Error bars are standard error
ral blood from asthmatic patients. Fold difference in ACSL3, IFN-γ and
om healthy control as referent = 1, as determined by quantitative
l shown under each bar. Error bars are standard error of the means.
Figure 2 Comparison of serum levels of IL-4 and IFN-γ in non-asthmatic and asthmatic subjects. Independent sample t-test was
performed for comparing non-asthmatic and asthmatic subjects. Data represented by Mean± standard deviation. Error bars represents standard
error of the means. (A) Serum IL-4 (ng/ml) concentration among non-asthmatic and asthmatic subjects. (B) Serum IFN-γ (ng/ml) concentration
among non-asthmatic and asthmatic subjects.
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were raised in asthmatic condition. We have also demon-
strated a significant correlation between cytokine mRNA
expression and serum PAH levels. Moreover, In vivo
chronic exposure of rats to benzopyrene resulted in over
expression of IL-4, the pattern that coincided the one ob-
served in asthma group.
The children with asthma had significantly lower HDL
cholesterol levels compared to those without asthma.
Low serum HDL cholesterol levels are one of the funda-
mental features of metabolic syndrome and have been
shown to affect cholesterol transportation and markers
of systemic inflammation in children [19]. The synthesis0.00
20.00
40.00
60.00
80.00
100.00
120.00
0.00 100.00 200.00 3
IL
-4
Σ
Figure 3 Correlation between serum IL-4 concentrations and PAH levof the alveolar surfactant is promoted by HDL particles
[20], which suggest that HDL may modulate the devel-
opment of inflammation in the lung. Indeed, several
studies have reported that high levels of plasma HDL
cholesterol are associated with a decreased risk of aller-
gic diseases [21,22]. A number of studies have found
high HDL cholesterol levels to be positively associated
with asthma [23]. Whereas, few others found no associa-
tions of serum HDL cholesterol with asthma outcomes
[17,24]. The results from our report are in agreement with
two others from the Third National Health and Nutrition
Examination Survey (NHANES) where they found that
high serum HDL cholesterol levels to be associated withr = 0.20
p = 0.01
00.00 400.00 500.00 600.00
 POP
els in studied subjects.
Table 3 Multivariate analysis using linear regression
model to show the association between cytokine IL4 and
IFN-γ and gene expression levels with serum PAHs
(ΣPOPs) controlled for age and BMI
Dependent
variable
Parameters R2 β (standardized
coefficients)
P value
IL-4 Gene expression
Levels
ΣPOP
0.19
0.36 <0.001
Age 0.18 0.08
BMI 0.20 0.05
IFN-γ Gene expression
Levels
ΣPOP
0.26
−0.40 <0.001
Age 0.19 0.06
BMI 0.31 0.002
Note: P-value significant at p < 0.05.
Al-Daghri et al. BMC Pediatrics 2014, 14:17 Page 6 of 8
http://www.biomedcentral.com/1471-2431/14/17higher lung function and reduced risk for allergic sen-
sitization in children [21,25]. Whereas, Yiallouros et al.
have demonstrated that Low-serum HDL cholesterol in
childhood is associated with an increased risk for asthma
in adolescence [23].
In asthma, there seems to be an increased expression
of Th2 cytokines, with an elevated production of IL-4,
IL-5 and IL-13 [5,26]. The present results corroborate
with these findings showing increased serum IL-4 ex-
pression in children with asthma. These increased serum
IL-4 expression was comparable with increased IL-4
mRNA expression in circulating PBMCs from children
with asthma. Olivenstein et. Al (14) have shown an in-
creased number of eosinophils and IL-4 and IL-5 mRNA
positive cells in the cellular component of induced spu-
tum of asthmatic subjects [14]. Further, Prieto et. al [6]
have reported increased IL-4 mRNA expression after cu-
mulative allergen provocation in BAL fluid cells and per-
ipheral CD4+ and CD8+ T cells. However, these patterns
of mRNA levels do not directly reflect protein produc-
tion and/or secretion by blood cells; it is still not clear
how much this accounts for their levels in the circulat-
ing blood.
In the current study, finding of lower serum levels of
IFN-γ in children with asthma is consistent with earlier
study [5]. But, IFN-γ mRNA expression levels in PBMC
were not significantly lower in children with asthma
than in controls. However, there is conflicting evidence
from previous studies observed in humans regarding the
relationship between the levels of IFN-γ and asthma.
Cho et al. [27] have reported that frequencies of un-
stimulated airway CD4+ and CD8+ T cells spontaneously
producing IFN-γ were increased in subjects with asthma
compared with control subjects [27]. Truyen et al. [28]
have reported that increased IFN‐γ mRNA levels were
found in the sputum of asthmatic subjects, predomin-
antly in those with moderate to severe asthma [28].
Whereas Kim et al. [29] reported that there is no differ-
ence in the IFN-γ level in BAL fluid amongst thechildren with acute asthma compare to those of no sign of
asthma [29]. In children with atopic asthma, Gemou-
Engesaeth et al. [30] have detected a high percentage of
PBMCs expressing mRNA for IL-4 but a normal percent-
age for IFN-γ compared with that of control subjects [30].
The data herein suggests that serum PAHs levels were
significantly higher in children with asthma than in con-
trols and a significant correlation was observed between
expression of IL-4, IFN- γ mRNA and serum PAH levels.
The PAH levels detected, likely reflect differences attrib-
utable to the ubiquitous traffic-related and other sources
of air pollution in the urban environment of the cohort
studied [2]. Several studies have documented increased
prevalence of asthma by indoor air pollution using un-
processed biomass fuels [31]. The common source of in-
door smoke to which children are frequently exposed in
Arabian countries is the Arabian incense (bakhour) [32].
Incense burning produces continuous smoke, generating
pollutants, such as toxic gases and chemical particles, in-
cluding polycyclic aromatic hydrocarbons, carbon monox-
ide, benzene, and isoprene that easily accumulate indoors,
especially under inadequate ventilation [33]. Exposure to
incense smoke has been associated with several conditions,
including respiratory symptoms, asthma, elevated cord
blood IgE levels, contact dermatitis and cancer [32]. Taken
together, these observations support the hypothesis that cir-
culating PAHs concentration may influence the blood cyto-
kine expression. To test this hypothesis in vivo, rats were
given i.p. injections of benzopyrene for three weeks. Not-
ably, this resulted in a significantly higher IL-4 mRNA ex-
pression in liver, lungs and blood tissues. However, there
were no significant changes in expression of ACSL3 and
IFN-γ mRNA expression in the above tissues except the
lungs, in which IFN-γ mRNA was significantly over
expressed (data not shown). Interestingly, this data in blood
of animal model was in line with the human data. Benzo(a)
pyrene (BaP) is one of the best qualified environmental
PAHs, which along with several BaP-quinones (BPQs) are
known to enhance IgE-mediated histamine release and
cytokine production by altering specific signaling pathways.
Pre-incubation of human basophils with BaP, 1,6-BPQ, and
3,6-BPQ, enhances histamine release and IL-4 production
after short exposure time [34].
Conclusions
In conclusion, the expression of cytokines we studied
reflected the clinical status of the participants. The ex-
pression of IL-4 mRNA in PBMC was correlated with
disease, and provided further evidence supporting the
close relation of this cytokine with asthmatic condition.
It does look that PAH level were raised in children with
asthma and our animal study further corroborate the ef-
fect of PAH on IL-4 production which at least partly
mediate the inflammatory response noticed in asthma.
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